LUMI-SPORYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lumi-sporyn, and when can generic versions of Lumi-sporyn launch?
Lumi-sporyn is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in LUMI-SPORYN is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUMI-SPORYN?
- What are the global sales for LUMI-SPORYN?
- What is Average Wholesale Price for LUMI-SPORYN?
Summary for LUMI-SPORYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| DailyMed Link: | LUMI-SPORYN at DailyMed |
Pharmacology for LUMI-SPORYN
| Drug Class | Aminoglycoside Antibacterial Polymyxin-class Antibacterial |
| Physiological Effect | Decreased Cell Wall Synthesis & Repair |
US Patents and Regulatory Information for LUMI-SPORYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | LUMI-SPORYN | bacitracin zinc; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 050417-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
